The NeuroblastomaPSM (Neuroblastoma Partitioned Survival Model) package documents the cost effectiveness of Dinutuximab Beta (Qarziba®) for the treatment of high-risk neuroblastoma patients after stem cell transplantation.
-
Updated
Jul 17, 2024 - R
The NeuroblastomaPSM (Neuroblastoma Partitioned Survival Model) package documents the cost effectiveness of Dinutuximab Beta (Qarziba®) for the treatment of high-risk neuroblastoma patients after stem cell transplantation.
Add a description, image, and links to the dinutuximab topic page so that developers can more easily learn about it.
To associate your repository with the dinutuximab topic, visit your repo's landing page and select "manage topics."